On Wednesday, the Financial Times reported that AstraZeneca was considering restarting its vaccine trial, only a day after they paused it following a patient falling ill. This comes as Pfizer and BioNTech have reportedly completed their deal with the European Union. Yahoo Finance’s Anjalee Khemlani breaks down the latest news about the coronavirus on The Final Round.
